Related Experiment Video

Updated: Sep 26, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[A prospective study of hypolipidemic therapy in young women after myocardial infarction]

A S Svistov, R Kh Galiullina, A G Obrezan

    Klinicheskaia Meditsina
    |March 26, 2003
    PubMed

    Insights

    Hypolipidemic drugs significantly improved ischemic heart disease (IHD) outcomes in women post-myocardial infarction (MI). This therapy was particularly beneficial for menopausal women, reducing IHD aggravation and improving disease course.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Public Health

    Background:

    • Ischemic heart disease (IHD) presents a significant health challenge, particularly in post-myocardial infarction women (PIW).
    • The course and severity of IHD can be influenced by factors such as age (pre- vs. post-menopausal) and comorbidities like hypertension.
    • Optimal management strategies for PIW require further investigation to improve long-term outcomes.

    Purpose of the Study:

    • To prospectively evaluate the efficacy of hypolipidemic drugs compared to standard antianginal treatment in women post-myocardial infarction.
    • To assess the impact of hypolipidemic therapy on the course and severity of IHD in different age groups of PIW.
    • To determine if hypolipidemic drugs can mitigate IHD aggravation and improve recovery in PIW.

    Main Methods:

    • A 3-year prospective clinical trial involving post-myocardial infarction women.
    • Comparison of two treatment groups: standard antianginal therapy alone versus antianginal therapy combined with hypolipidemic drugs.
    • Stratification of participants based on menopausal status and assessment of IHD course, including frequency of aggravation and improvement.

    Main Results:

    • Ischemic heart disease (IHD) generally followed a less severe course in younger post-myocardial infarction women (PIW) compared to menopausal PIW.
    • IHD aggravation was more frequent in PIW with a history of previous myocardial infarction (MI) and in those with hypertension.
    • Hypolipidemic drugs significantly improved the course of IHD in PIW. Improvement occurred 6.2 times more frequently and aggravation 2.3 times less frequently in menopausal women on hypolipidemic drugs versus those on antianginal treatment alone. Young women showed a 1.6 times greater benefit from hypolipidemic therapy.

    Conclusions:

    • Hypolipidemic drug therapy represents a valuable addition to standard antianginal treatment for post-myocardial infarction women.
    • The benefits of hypolipidemic therapy are pronounced in menopausal women, leading to more frequent IHD improvement and less frequent aggravation.
    • Early intervention with hypolipidemic drugs may be beneficial for improving IHD outcomes in younger post-myocardial infarction women as well.

    Related Concept Videos

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

    Blood Studies for Cardiovascular System III: Serum Lipid Profile

    Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
    Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
    Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Ischemic Heart Disease: Overview01:17

    Ischemic Heart Disease: Overview

    Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
    Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...